Chronadalate Lp en es it fr

Chronadalate Lp Brand names, Chronadalate Lp Analogs

Chronadalate Lp Brand Names Mixture

  • No information avaliable

Chronadalate Lp Chemical_Formula

C17H18N2O6

Chronadalate Lp RX_link

http://www.rxlist.com/cgi/generic2/nifedip.htm

Chronadalate Lp fda sheet

Chronadalate_Lp FDA

Chronadalate Lp msds (material safety sheet)

Chronadalate_Lp MSDS

Chronadalate Lp Synthesis Reference

Bossert, Vater, U.S. Pat. 3,485,847 (1969)

Chronadalate Lp Molecular Weight

346.335 g/mol

Chronadalate Lp Melting Point

172 - 174 oC

Chronadalate Lp H2O Solubility

Insoluble

Chronadalate Lp State

Solid

Chronadalate Lp LogP

2.343

Chronadalate Lp Dosage Forms

Capsule; Tablet; Tablet (extended-release)

Chronadalate Lp Indication

For the management of vasospastic angina, chronic stable angina and hypertension.

Chronadalate Lp Pharmacology

Nifedipine, the prototype of the dihydropyridine class of calcium-channel antagonists, is similar to other dihydropyridines including amlodipine, felodipine, isradipine, and nicardipine. Nifedipine is used to treat Prinzmetal's angina, hypertension, and other vascular disorders such as Raynaud's phenomenon. By blocking the calcium channels, Nifedipine inhibits the spasm of the coronary artery and dilates the systemic arteries, results in a increase of myocardial oxygen supply and a decrease in systemic blood pressure.

Chronadalate Lp Absorption

Rapidly and fully absorbed following oral administration.

Chronadalate Lp side effects and Toxicity

Symptoms of overdose include dizziness, drowsiness, nausea, severe drop in blood pressure, slurred speech, and weakness. LD50=494 mg/kg (orally in mice); LD50=1022 mg/kg (orally in rats)

Chronadalate Lp Patient Information

Chronadalate Lp Organisms Affected

Humans and other mammals